NP694025.RAnxW0Dq-pkHxvN ybkTs2S1HB-ndEoPNCB9-UoxgHmf0
type: Nanopublication
has assertion: NP694025.RAnxW0Dq-pkHxvN ybkTs2S1HB-ndEoPNCB9-UoxgHmf0130 assertion
has provenance: NP694025.RAnxW0Dq-pkHxvN ybkTs2S1HB-ndEoPNCB9-UoxgHmf0130 provenance
has publication info: NP694025.RAnxW0Dq-pkHxvN ybkTs2S1HB-ndEoPNCB9-UoxgHmf0130 publicationInfo
created: 2015-08-25T14:44:38+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v3.0.0.0

NP694025.RAnxW0Dq-pkHxvN ybkTs2S1HB-ndEoPNCB9-UoxgHmf0130 assertion
type: Assertion
description: [SIAH-2 deficiency in human lung cancer cell lines reduced MAPK signaling and statistically significantly inhibited cell proliferation compared with those in SIAH-proficient cells (P < .001) and increased apoptosis (TUNEL-positive A549 cells 3 days after lentivirus infection: SIAH-2(PD) vs control, 30.1% vs 0.0%, difference = 30.1%, 95% confidence interval [CI] = 23.1% to 37.0%, P < .001; SIAH-2-shRNA#6 vs control shRNA, 27.9% vs 0.0%, difference = 27.9%, 95% CI = 23.1% to 32.6%, P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/19001609
was generated by: ECO_0000203

befree-20150227
imported on: 2015-02-27

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v3.0.0